1. Introduction
Bioinformatics is an emerging biological discipline, constituting a unique blend of basic biology, genetics, and information sciences. It focuses on the technological advancements in the collection and processing of biological data, including DNA sequence data, RNA, and cDNA sequence data, as well as protein sequence information, and the utilization of this data for biological exploration and prediction using digital technology [
1,
2]. Over the past decades, a plethora of bioinformatics software and databases have been developed to analyze the flood of omics data (genomics, transcriptomics, proteomics, and metabolomics) and interpret their biological significance [
3]. Due to this omics era, sequencing data are publicly available in databases such as GenBank, Ensembl and others (
Table 1), which integrate nucleotide sequences and biological annotations, making them widely accessible for the identification of genes responsible for secondary metabolism [
2].
Gene annotation software and databases helps reveal conserved regions of genes across organisms. Accurate prediction tools help us understand how fungal genes in genomes are structured and organized, and how evolutionary principles may affect the same sets of genes in different fungal species. These tools are certain to influence fungal biotechnology efforts, as key findings in the conservation of gene structures also assist in understanding conserved functions among fungal species [
8].
With the increasing availability of fungal genomes, there has been a rapid growth in foreseeing and identifying putative Secondary Metabolites (SMs) formation genes by analyzing sequence similarities of fungal DNA compared to characterized Biosynthetic Gene Clusters (BGCs), allowing for the identification of biosynthesis genes and prediction of their functions [
9,
10]. Generally, accurate predictions can be made for the class of SM (e.g., polyketides, peptides, terpenes, etc.) and, in some cases, the core structures of the SMs [e.g., products of type I polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs) [
11].
Botrytis cinerea-induced grey mold is widely recognized as a primary contributor to postharvest losses across a diverse spectrum of crops, encompassing fruits, vegetables, cut flowers, and flower bulbs [
12]. Diseases incited by
Botrytis species, particularly
B. cinerea, hold a preeminent position on the global stage of plant pathology. This pre-eminence can be attributed to a combination of factors: the extraordinary breadth of host range exhibited by
Botrytis spp., with
B. cinerea being of prominence; the capacity to initiate quiescent infections; an impressive ability to adapt to diverse ecological niches; genetic malleability, encompassing adaptations to fungicides; the absence of host resistance mechanisms; and a versatile ecological niche transitioning from saprophyte to pathogen. One of the crucial weapons that this pathogen possess is the production of (non-specific) phytotoxic compounds to kill cells of a range of plant species [
12]. In the pre-genomic era of
B. cinerea research, eight families of SM were already isolated from in vitro mycelium. In particular, the predominant metabolites botrydial and botcinic acid were identified as two unspecific phytotoxins contributing to the necrotrophic and polyphagous lifestyle of the fungus [
13].
Recognizing the pivotal role that
B. cinerea plays among plant pathogens, its complete genome sequence has been meticulously determined [
14]. The initial genome assemblies of strains B05.10 (Syngenta AG) and T4 (Genoscope) were generated using Sanger sequencing technology. Subsequently, Staats and van Kan improved genome assemblies of these strains using NGS Illumina technology [
14]. Finally, in 2017, van Kan
et al. reported the utilization of novel sequence data, partly derived from third-generation sequencing platforms, in combination with an optical map and a genetic map, to create a gapless, nearly complete genome assembly of the
B. cinerea isolate B05.10 [
15].
To identify the pathways involved in the production of other SMs in
B. cinerea, a search among the genomes for genes encoding key enzymes such as NRPS (Non-Ribosomal Peptide Synthetases), PKS (PolyKetide Synthases), TS (Terpene Synthase) and DMATS (DiMethylAllylTryptophan Synthases), which are essential for the biosynthesis of peptides, polyketides, terpenes, and alkaloids, respectively [
12]. Traditionally, a total of 44 genes encoding enzymes responsible for the committed biosynthetic step (called “Key” Enzyme, KE) were predicted from the sequences of the B05.10 and T4 strains [
13,
15].
In this work, a bioinformatic analysis was conducted using publicly available and searchable databases. The organization of candidate genes possibly related to secondary metabolism by the domains to which they belong has enabled us to compile 64 new genes possibly involved in the SM production of B. cinerea.
2. Results
As results derived from a bioinformatic analysis targeting the genomics of B. cinerea, with a specific focus on genes implicated in secondary metabolism, we utilized a synergistic approach that combined cutting-edge bioinformatic tools and genomic databases. This approach has elucidated the presence and configuration of diverse gene families associated with the biosynthesis of secondary metabolites—critical to the pathogenicity and adaptability of B. cinerea. This analysis not only reaffirmed the identification of previously characterized genes within the context of fungal secondary metabolism but also unveiled candidate genes hitherto undescribed, potentially involved in the synthesis of novel compounds. The results are structured and presented according to the principal gene families involved in the biosynthesis of polyketides (PKS), non-ribosomal peptides (NRPS), terpenoids, and other secondary metabolites. This organization offers a detailed overview of the complexity and richness of the genetic repertoire of B. cinerea dedicated to the production of these bioactive compounds.
Along manuscript we developed tables through a systematic approach to encapsulate the intricate relationship between genes of B. cinerea and secondary metabolism, leveraging insights from our bioinformatic analysis. As is shown in , for constructing these tables, the first column, labeled 'Name,' delineates the gene names, with newly identified genes not previously annotated or published marked by a dash to highlight their novelty. The 'ID' column follows, specifying the Gene ID as referenced within the Ensembl Fungi and FungiDB platforms, thereby providing a tangible link to the genomic underpinnings pertinent to our study. A pivotal aspect of our methodology is the color-coded 'Relationship with secondary metabolism' column, which denotes the gene's association with secondary metabolism based on database inquiries. This categorization spans from generic secondary metabolic processes to more specific involvements, such as polyketides synthases (PKS), non-ribosomal peptides (NRPS), or terpene synthases (TS), with the former two categories offering a broader context and the latter two pinpointing direct biochemical roles.
For each gene, we looked for 'Paralogous Genes', showing the results in the correspondent column, which compiles both known and yet-to-be-referenced paralogous genes, with unreferenced genes marked by their ID and known genes by their established nomenclature. This delineation underscores that the genes identified as new candidates in our tables share functional similarities with known genes, highlighting their potential roles in secondary metabolism. To ensure clarity and minimize redundancy across the gene families, we employed symbols such as asterisks (*) to indicate genes sharing identifiers with those listed undescribed and with double asterisks (**) denoting continuity without the need for repetitive listings. The notation "NA" signals the absence of paralogous genes, while additional symbols like ♣ and Δ differentiate among gene families, ensuring a coherent categorization. This meticulous table construction aims to provide a comprehensive and accessible overview of the genetic repertoire of B. cinerea related to secondary metabolism, illuminating novel genes potentially involved in its complex biosynthetic networks.
2.1. Genes Located in Domains That Code for Possible PKSs in B. cinerea
Expanding on the genomic framework of
B. cinerea introduced earlier, this section focuses on the analysis of polyketide synthases (PKS) genes identified through bioinformatics. PKSs are essential for synthesizing a wide range of polyketides, which are crucial for the fungus's adaptability, pathogenicity, and survival [
16] The diversity observed in the domains of PKS genes reflects the complexity of
B. cinerea's secondary metabolism and its evolutionary adaptation for interacting with hosts and the environment.
Our genomic exploration revealed a substantial array of PKS genes, each harboring distinct domains critical for the polyketide production pathway. In the case of polyketide synthases, eight domains have been identified, encompassing both previously described and undescribed genes, underscoring the ongoing expansion of our understanding of PKS complexity [
17]. These domains, listed in
Table 2, range from the polyketide synthase dehydratase domain to the phosphopantetheine-binding domain, each playing a unique role in the enzymatic assembly and modification of polyketide chains. The domains of the dehydratase superfamily (IPR042104), acyl transferase (IPR020801), ketoreductase (IPR013968), and phosphopantetheine-binding (IPR020806) include genes that have not been described to date, in addition to those that are already known. The other domains detailed in
Table 2 exclusively contain genes that have been previously identified. Notably, the
Bcchs1 gene, diverging by coding for a PKS involved in the production of pyrones, resorcilic acids, and resorcinols, showcases a thiolase-like domain (IPR016039), hinting at the presence of additional genes that could encode PKSs with similar functions.
This diversity of domains, indicative of the organism's capacity to produce a myriad of polyketide compounds, is pivotal not only for the pathogen’s adaptability and survival but also for its virulence against plant hosts. The elucidation of these PKS domains and their associated genes, as detailed in
Table 2, opens new avenues for targeted antifungal strategies by identifying potential vulnerabilities in the pathogen's metabolic pathways. By understanding the specific roles of different PKS domains in metabolite biosynthesis, researchers can identify potential targets for the development of novel fungicides that inhibit critical steps in polyketide synthesis, offering a blueprint for engineering disease-resistant crops.
The exploration of specific PKS domains, such as those of the dehydratase superfamily, acyl transferase, ketoreductase, and phosphopantetheine-binding, has identified previously undescribed genes, suggesting uncharted pathways in polyketide biosynthesis. Expanding the known genetic repertoire of
B. cinerea underscores the potential to discover new bioactive compounds with agricultural and pharmaceutical applications.
Table 3 elaborates on the newly identified and previously unannotated genes within the PKS domains of
B. cinerea. This table specifically focuses on detailing the genes associated with each PKS domain, shedding light on their potential roles in the biosynthesis of polyketides and their contribution to the fungus's secondary metabolic capabilities.
Table 3.
Genes located in the domains that code for possible PKSs in B. cinerea.
Table 3.
Genes located in the domains that code for possible PKSs in B. cinerea.
Polyketide synthase, dehydratase domain superfamily. Domain:IPR042104 (Gene3D) |
name |
ID |
Relationship with secondary metabolism |
Paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
Bcpks5 |
Bcin01g11550 |
|
|
|
|
Bcin03g06470; Bcin09g06360; Bcin08g02570; Bcin08g02560; Bcin12g03250* |
Bcboa6; 9; Bcpks5; 2; 12; 18; 17; 3; 13; 20; 15; 21; 8; 19; 7; 4; 10; 1; 11; 14¸16 and Bccem1 ** |
Bcpks2 |
Bcin02g01680 |
|
|
|
|
Bcpks12 |
Bcin02g08770 |
|
|
|
|
NA |
NA |
Bcpks18 |
Bcin02g08830 |
|
|
|
|
* |
** |
Bcpks17 |
Bcin03g02010 |
|
|
|
|
Bcpks3 |
Bcin03g04360 |
|
|
|
|
Bcpks13 |
Bcin03g08050 |
|
|
|
|
Bcpks20 |
Bcin04g00640 |
|
|
|
|
Bcpks15 |
Bcin05g06220 |
|
|
|
|
Bcpks21 |
Bcin05g08400 |
|
|
|
|
Bcpks8 |
Bcin07g02920 |
|
|
|
|
Bcpks19 |
Bcin08g00290 |
|
|
|
|
- |
Bcin09g06350 |
|
|
|
|
NA |
NA |
Bcpks7 |
Bcin10g00040 |
|
|
|
|
* |
** |
Bcpks4 |
Bcin11g02700 |
|
|
|
|
Bcpks10 |
Bcin13g01510 |
|
|
|
|
Bcpks1 |
Bcin14g00600 |
|
|
|
|
NA |
NA |
Bcpks11 |
Bcin14g01290 |
|
|
|
|
* |
** |
Bcpks14 |
Bcin16g01830 |
|
|
|
|
Bcpks16 |
Bcin16g05040 |
|
|
|
|
Bcboa6 |
Bcin01g00060 |
|
|
|
|
Bcboa9 |
Bcin01g00090 |
|
|
|
|
|
Polyketide synthase, acyl transferase domain. Domain IPR020801 (SMART) |
There are the genes of the last domain IPR042104, except Bcin09g06350. In addition there are the following genes as new for this domain IPR020801. |
name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
- |
Bcin01g00450 |
|
|
|
|
NA |
NA |
- |
Bcin04g00210 |
|
|
♦ |
|
Bcin01g00450 |
Bcfas2
|
|
Polyketide synthase, ketoreductase domain. Domain IPR013968 (Pfam) |
There are the genes of the domain IPR042104, except Bcpks12; 18; 17; 13; 19; 15; 14; 16; Bcin09g06350. In addition there are the following genes as new for this domain IPR013968. |
name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
- |
Bcin03g06470 |
|
|
҉ |
|
between them and Bcin08g02560; Bcin12g03250 |
** |
- |
Bcin08g02570 |
|
|
҂ |
|
- |
Bcin09g06360 |
|
|
҉ |
|
- |
Bcin11g04550 |
|
|
|
|
NA |
NA |
|
Polyketide synthase, phosphopantetheine-binding domain. Domain IPR020806 (SMART) |
There are the genes of the domain IPR042104, except Bcpks18; 17; 20; 14; 16; 14; 16; Bcboa9; Bcin09g06350 also the gene Bcin03g06470. In addition there are the following genes as new for this domain IPR020806
|
name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
Bcnrps6 |
Bcin01g03730 |
♦ |
|
|
|
Bcin01g04420; Bcin01g08480; Bcin02g04610; Bcin02g06290; Bcin03g00210; Bcin03g00220: Bcin03g01550; Bcin03g01570; Bcin04g03150; Bcin06g02740; Bcin07g02750; Bcin07g02790; Bcin07g05830; Bcin08g03980; Bcin08g04860; Bcin09g02040; Bcin09g02790; Bcin10g01270; Bcin11g01420; Bcin11g02680; Bcin12g00620; Bcin12g05070; Bcin12g05180; Bcin12g05840; Bcin13g02260; Bcin15g00920; Bcin15g02940; Bcin15g04320; Bcin17g00050 *** |
Bcnrps7; 4; 5; 8; 2; 1; 9; 3; Bclys2 and Bcpcs60 **** |
- |
Bcin02g00016 |
♦ |
|
♦ |
|
Bcin01g02950; Bcin01g10250; Bcin05g07000; Bcin06g00140; Bcin06g01300; Bcin06g04410; Bcin06g04960; Bcin07g04170; Bcin08g05600; Bcin09g03540; Bcin14g03680 Bcin15g03200 Δ
|
Bcfaa2Δ Δ
|
Bcnrps4 |
Bcin02g02380 |
|
|
♦ |
|
*** |
**** |
- |
Bcin03g00210 |
♦ |
|
҉ |
|
- |
Bcin03g01570 |
|
|
҉ |
|
Bclys2 |
Bcin04g00140 |
♦ |
|
|
|
*** |
**** |
- |
Bcin07g05830 |
|
|
҉ |
|
- |
Bcin09g02040 |
|
|
♦ |
|
- |
Bcin11g01420 |
|
|
♦ |
|
Bcnrps8 |
Bcin11g02650 |
|
|
|
|
Bcnrps2 |
Bcin12g00690 |
♦ |
|
♦ |
|
Bcnrps9 |
Bcin14g01300 |
♦ |
|
♦ |
|
Bcnrps3 |
Bcin16g03570 |
♦ |
|
♦ |
|
|
Thiolase-like. Domain IPR016039 (Gene3D) |
There are the genes of the domain IPR042104, except Bcin09g06350. In addition there are the following genes as new for this domain IPR016039 |
name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
Bcfas2 |
Bcin01g00440 |
|
|
|
|
Bcin01g00450 Bcin04g00210 |
NA |
Bcpot1 |
Bcin01g04960 |
|
|
♦ |
|
Bcin03g03940; Bcin04g06330; Bcin06g05400 Bcin12g00940 ***** |
Bcerg10 |
- |
Bcin03g03940 |
|
|
♦ |
|
Bcin04g06330 Bcin12g00940 |
Bcpot1 and Bcerg10 ****** |
- |
Bcin04g04450 |
|
|
|
|
NA |
Bcerg13 |
- |
Bcin04g06330 |
|
|
♦ |
|
***** |
****** |
Bcerg10 |
Bcin05g07430 |
|
|
♦ |
|
***** |
Bcpot1 |
- |
Bcin06g05400 |
|
|
♦ |
|
***** |
****** |
- |
Bcin06g07420 |
|
|
|
|
NA |
NA |
Bcerg13 |
Bcin11g00330 |
|
|
|
|
Bcin04g04450 |
****** |
- |
Bcin12g00940 |
|
|
♦ |
|
***** |
Bccem1 |
Bcin16g02410 |
|
|
|
|
* |
** |
1 |
|
EnsemblFungi. Biological process: GO:0044550 secondary metabolite biosynthetic process. IEA. |
♦ |
Fungi DB. Metabolic pathway: Biosynthesis of various other secondary metabolites (KEGG) |
2 |
|
EnsemblFungi. Biological process. GO:0009058 biosynthetic process. IEA. |
3 |
|
Fungi DB. Metabolic pathway. Biosynthesis of type II polyketide backbone and products (KEGG) |
♦ |
Fungi DB. Metabolic pathway: aromatic polyketides biosynthesis (MetaCyc) |
҉ |
NCBI: smart00823: PKS_PP; Phosphopantetheine attachment site (SMART) |
҂ |
Fungi DB. Uniprot. SM00822. PKS_KR (SMART) |
4 |
|
Fungi DB. Metabolic pathway. Biosynthesis of siderophore group nonribosomal peptides (KEGG) |
As can be observed in
Table 3, following the comprehensive analysis based on the domains of these PKS genes, a total of 19 genes with domains belonging to this family have been identified, which have not yet been annotated. Specifically, 1 gene with a dehydratase domain (IPR042104), 2 genes with an acyl transferase domain (IPR020801), 4 genes with a ketoreductase domain (IPR013968), 6 genes with a phosphopantetheine-binding domain (IPR020806), and 6 genes with a thiolase-like domain (IPR016039) have been located. These newly identified genes allow for the expansion of the list of the 18 PKS-coding genes previously annotated for
B. cinerea [
18].
The identification of paralogous genes within the PKS domains, as meticulously cataloged in
Table 3, presents an interesting glimpse into the genetic diversity and evolutionary dynamics of
B. cinerea. For instance, the presence of multiple paralogues for the
Bcpks genes, including
Bcpks5 highlighted by its association with several identified paralogs such as Bcin03g06470, Bcin09g06360, and others, underpins the evolutionary strategy of gene duplication and divergence that
B. cinerea may exploit to enhance its biosynthetic versatility and adaptability. This notion is further supported by the distinct domains these PKS genes occupy, ranging from dehydratase to phosphopantetheine-binding domains, each contributing uniquely to the polyketide synthesis pathway.
The unveiling of previously unannotated genes within the PKS domains in
Botrytis cinerea, as presented in
Table 3, enhances our comprehension of the fungus's PKS gene spectrum and hints at the existence of yet-to-be-explored metabolic routes. These routes may play crucial roles in the organism's adaptability and pathogenic prowess. The detection of such genetic variance, highlighted by paralogous gene relationships, indicates a sophisticated mechanism that allows
B. cinerea to navigate environmental challenges effectively [
19]. This adaptability, potentially leading to the emergence of novel or altered secondary metabolites, might offer the fungus distinct ecological and pathogenic advantages, including heightened virulence or increased resistance to antifungal agents [
20].
This foray into the PKS domains and their paralogous gene sets not only sheds light on the secondary metabolism's complexity but also on the evolutionary strategies employed by
B. cinerea [
21]. It lays the groundwork for a deeper functional analysis of both established and novel genes, steering toward the discovery of innovative bioactive compounds. Moreover, it propels forward the development of precise antifungal interventions aimed at exploiting vulnerabilities within the pathogen's secondary metabolic pathways.
2.2. Genes Located in Domains That Code for Possible NRPSs in B. cinerea
Following the analysis of
B. cinerea's genome, this section examines the non-ribosomal peptide synthetases (NRPS) genes identified through bioinformatics. NRPS enzymes are key in synthesizing non-ribosomal peptides, important for the fungus's adaptability and virulence. The diversity in NRPS gene domains reflects
B. cinerea's secondary metabolic capacity and suggests an evolutionary adaptation for host and environmental interaction [
22].
Our bioinformatic analysis revealed several NRPS genes, each with specific domains essential for peptide synthesis. We identified ten distinct domains, including both known and new genes, which expands our understanding of the NRPS gene family in
B. cinerea [
23]. These domains, listed in
Table 4, cover functions from amino acid activation to peptide elongation and modification. For example, genes with a phosphopantetheine-binding domain play a crucial role in peptide intermediate activation and transfer.
The characterization of these NRPS domains and their genes, as presented in
Table 4, contributes to a better understanding of
B. cinerea's ability to produce diverse peptides. Understanding the roles of different NRPS domains in biosynthesis may lead to the identification of key points for intervention, offering opportunities for developing fungicides and enhancing crop resistance.
Among the ten domains detailed in
Table 4, the Condensation domain (IPR042099) stands out as the sole domain encompassing genes that have been previously characterized. The remaining domains are marked by the presence of genes that, until now, remain unannotated, unveiling a landscape ripe for exploration. This distinction underscores the potential breadth of B. cinerea's NRPS genetic repertoire, pointing to a wealth of unexplored pathways that could significantly impact the fungus's adaptability and pathogenicity.
Table 5 elaborates on the genes discovered within these NRPS domains, offering insights into both recognized and novel entities. Such information enriches our comprehension of the NRPS domains, shedding light on the genetic mechanisms potentially driving the synthesis of non-ribosomal peptides crucial to Botrytis cinerea's survival and virulence.
Table 5.
Genes located in the domains that code for possible NRPSs in B. cinerea.
Table 5.
Genes located in the domains that code for possible NRPSs in B. cinerea.
ACP-like superfamily. Domain: IPR036736 (Gene 3D) |
There are all the genes of the domain IPR024104 (Polyketide synthase, dehydratase domain superfamily), the domain IPR020806 (Polyketide synthase, phosphopantetheine-binding domain) and the gen Bcin09g06360 of the domain IPR013968 (Polyketide synthase, ketoreductase domain). In addition there are the following genes as new for this domain IPR036736 |
name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
Bccap1 |
Bcin02g08010 |
|
|
|
|
NA |
NA |
- |
Bcin03g01550 |
|
|
♦ |
|
*** |
**** |
- |
Bcin06g04410 |
|
|
|
|
Δ |
Δ Δ |
- |
Bcin07g01010 |
|
|
♦ |
|
NA |
NA |
- |
Bcin07g02790 |
|
|
♦ |
|
*** |
**** |
- |
Bcin15g00920 |
|
|
♦ |
|
- |
Bcin17g00050 |
♦ |
|
|
|
|
|
|
|
|
|
|
|
Amino acid adenylation domain. Domain IPR010071 (TIGRFAM) |
There are the genes of the domain IPR020806 (Polyketide synthase, phosphopantetheine-binding domain) except Bcin03g01570; Bcin03g06470; Bcin09g02040 and Bcin11g01420. In addition there are the following genes as new for this domain IPR010071 |
name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
Bcnrps5 |
Bcin04g01390 |
|
|
|
|
*** |
**** |
|
|
|
|
|
|
|
|
AMP-binding, conserved site. Domain IPR020845 (PROSITE patterns) |
There are the genes Bcnrps6, 4, 2, 9, 3; Bclys2; Bcpks5, 3, 7; Bcin02g00016; Bcin03g00210; Bcin03g01550; Bcin03g01570; Bcin06g04410; Bcin07g01010; Bcin07g02790; Bcin07g05830; Bcin15g00920 and Bcin17g00050. In addition there are the following genes as new for this domain IPR020845 |
name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
- |
Bcin01g10250 |
♦ |
|
|
|
Δ |
ΔΔ |
Bcnrps7 |
Bcin01g11450 |
♦ |
|
|
|
*** |
**** |
- |
Bcin02g04610 |
|
|
|
|
Bcfaa2 |
Bcin04g00760 |
|
|
|
|
Δ |
NA |
Bcpcs60 |
Bcin04g01320 |
♦ |
|
|
|
*** |
**** |
- |
Bcin04g03150 |
|
|
♦ |
|
NA |
NA |
- |
Bcin05g07000 |
|
|
|
|
Δ |
ΔΔ |
- |
Bcin06g00140 |
♦ |
|
♦ |
|
- |
Bcin06g01300 |
|
|
|
|
- |
Bcin06g04960 |
♦ |
|
|
|
- |
Bcin07g02750 |
|
|
|
|
*** |
**** |
- |
Bcin07g04170 |
|
|
|
|
Δ |
ΔΔ |
- |
Bcin08g03980 |
♦ |
|
|
|
*** |
**** |
- |
Bcin08g04860 |
|
|
|
|
- |
Bcin08g05600 |
♦ |
|
|
|
Δ |
ΔΔ |
- |
Bcin09g02790 |
|
|
♦ |
|
*** |
**** |
- |
Bcin09g03540 |
|
|
|
|
Δ |
ΔΔ |
- |
Bcin11g02680 |
|
|
|
|
*** |
**** |
Bcnrps1 |
Bcin12g04980 |
♦ |
|
|
|
- |
Bcin13g02260 |
|
|
|
|
- |
Bcin14g03680 |
♦ |
|
|
|
Δ |
ΔΔ |
- |
Bcin15g04320 |
♦ |
|
|
|
*** |
**** |
|
|
|
|
|
|
|
|
AMP-dependent synthetase/ligase. Domain IPR000873 (Pfam) |
There are the genes of the domain IPR020806 (Polyketide synthase, phosphopantetheine-binding domain); except Bcin03g06470; all the genes of the domain IPR020845; Bcpks3, 7; Bcnrps1, 5, 7; Bcfaa2 and Bcpcs60. In addition there are the following genes as new for this domain IPR000873 |
name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
- |
Bcin01g02950 |
|
|
|
|
Δ |
ΔΔ |
- |
Bcin01g04420 |
|
|
|
|
*** |
**** |
- |
Bcin01g08480 |
|
|
|
|
- |
Bcin02g06290 |
|
|
|
|
- |
Bcin10g00460 |
|
|
|
|
NA |
NA |
- |
Bcin10g01270 |
|
|
|
|
*** |
**** |
- |
Bcin12g00620 |
|
|
|
|
- |
Bcin12g05070 |
|
|
|
|
|
|
|
|
|
|
|
|
ANL, N-terminal domain. Domain IPR042099 (Gene 3D) |
There are all the genes of the domain IPR020806 (Polyketide synthase, phosphopantetheine-binding domain) except Bcin03g06470; the genes of the domain IPR000873 except Bcin12g05070; the genes of the domain IPR036736 except Bcin09g06360; the genes of the domain IPR020845 except Bcfaa2, Bcin05g07000, Bcin07g04170, Bcin08g05600. The genes Bcpks7, 5; Bcnrps5; Bcin03g01550; Bcin06g04410. In addition there are the following genes as new for this domain IPR042099 |
Name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
- |
Bcin03g00060 |
|
|
|
|
Bcin08g01790 |
NA |
- |
Bcin06g02740 |
|
|
|
|
*** |
**** |
- |
Bcin08g01790 |
|
|
|
|
Bcin03g00060 |
NA |
|
|
|
|
|
|
|
|
Chloramphenicol acetyltransferase-like domain superfamily. Domain IPR023213 (Gene3D) |
There are the genes Bcnrps6, 7, 4, 8, 2, 1, 9, 3; Bcpks5, 2, 3, 7 and Bcin06g04410. In addition there are the following genes as new for this domain IPR023213 |
Name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
Bcboa11 |
Bcin01g00110 |
|
|
♦ |
|
Bcin01g05970; Bcin07g07120 and Bcin15g04760 ♣
|
Bcayt1♣♣
|
- |
Bcin01g05970 |
|
|
♦ |
|
♣ |
♣♣ |
- |
Bcin02g02420 |
|
|
♦ |
|
NA |
Bccat2 |
Bckgd2 |
Bcin02g06820 |
|
|
♦ |
|
Bcin11g04250 |
Bcpdx1 and Bccat2
|
Bccat2 |
Bcin03g07910 |
|
|
♦ |
|
Bcin02g02420 |
NA |
- |
Bcin07g07120 |
|
|
♦ |
|
NA |
NA |
- |
Bcin08g00330 |
|
|
|
|
NA |
NA |
- |
Bcin11g04250 |
♦ |
|
♦ |
|
NA |
Bckgd2; Bcpdx1 and Bcclat1
|
Bclat1 |
Bcin12g05730 |
|
|
♦ |
|
Bcin11g04250 |
Bckgd2 and Bcpdx1
|
Bcbot5 |
Bcin12g06410 |
|
|
|
|
NA |
NA |
Bcayt1 |
Bcin15g00050 |
|
|
♦ |
|
♣ |
Bcboa11 |
- |
Bcin15g04760 |
|
|
♦ |
|
|
|
|
|
|
|
|
|
Phosphopantetheine attachment site. Domain IPR006162 (PROSITE patterns) |
There are the genes Bcboa6; Bcnrps6, 4, 8, 2, 1, 9; Bcpks12, 17, 20, 15, 19, 7, 1; Bcin03g00210, Bcin03g01550, Bcin03g06470 and Bcin07g05830. |
|
Phosphopantetheine binding ACP domain. Domain IPR009081 (PROSITE profiles) |
There are the genes Bcboa6, 9; Bcnrps6, 4, 8,5, 2, 1, 9, 3; Bcpks5, 2, 12, 18, 17, 3, 13, 20, 15, 21, 8, 19, 4, 7, 10, 11, 1, 14, 16; Bcfas2; Bclys2; Bcin02g00016, Bcin03g00210, Bcin03g01550, Bcin03g01570, Bcin03g06470, Bcin07g01010, Bcin07g02790, Bcin07g05830, Bcin09g02040, Bcin09g06360; Bcin11g01420; Bcin15g00920 and Bcin17g00050 |
|
Polyketide synthase, phosphopantetheine-binding domain. Domain IPR020806 (SMART) |
There are the genes Bcboa6; Bcnrps6, 4, 8, 5, 2, 9, 3; Bcpks5, 2, 12, 13, 15, 21, 8, 19, 7, 4, 10, 1, 11, 16; Bclys2; Bcin02g00016, Bcin03g00210, Bcin03g01570, Bcin03g06470, Bcin07g05830, Bcin09g02040 and Bcin11g01420 |
1 |
|
EnsemblFungi. Biological process: GO:0044550 secondary metabolite biosynthetic process. IEA. |
♦ |
Fungi DB. Metabolic pathway: Biosynthesis of various other secondary metabolites (KEGG) |
2 |
|
EnsemblFungi. Biological process. GO:0009058 biosynthetic process. IEA. |
3 |
|
Fungi DB. Metabolic pathway. Biosynthesis of type II polyketide backbone and products (KEGG) |
♦ |
Fungi DB. Metabolic pathway: aromatic polyketides biosynthesis (MetaCyc) |
4 |
|
Fungi DB. Metabolic pathway. Biosynthesis of siderophore group nonribosomal peptides (KEGG) |
As detailed in
Table 5, a comprehensive analysis based on the domains of NRPS genes has identified a total of 41 genes within domains attributed to this family that have not yet been annotated. Specifically, 6 genes were located in the ACP-like superfamily domain (IPR036736), 18 genes within the AMP-binding domain (IPR020845), 8 genes in the AMP-dependent synthetase/ligase domain (IPR000873), 3 genes in the ANL, N-terminal domain (IPR042099), and 6 genes in the Chloramphenicol acetyltransferase-like domain superfamily (IPR023213). The revelation of these genes notably expands the potential repertoire of NRPS beyond the 9 previously annotated, suggesting a broader scope for secondary metabolic diversity within this pathogenic fungus [
18]. This enumeration of domains harboring both recognized and newly discovered genes underscores the intricate genetic architecture that underpins the non-ribosomal peptide synthesis capability of B. cinerea, laying a foundation for future explorations into its secondary metabolism.
2.3. Genes Located in Domains That Code for Possible STCs in B. cinerea
In
Section 2.3, the focus extends to genes encoding Sesquiterpene Cyclases (STCs), pivotal in the biosynthesis of sesquiterpenes, which are key contributors to B. cinerea's arsenal of bioactive compounds. These enzymes are responsible for the cyclization of farnesyl diphosphate (FPP) to yield a variety of sesquiterpenes, not only including the phytotoxic botrydial, which instigates chlorosis and necrosis in host tissues [
24], but also abscisic acid, a well-documented mediator of plant stress responses and a facilitator of pathogen attack [
25]. Furthermore, the recently elucidated group of 4-epi-eremophil-9-en-11-ols adds to this complex metabolic repertoire, indicating a sophisticated chemical ecology that underpins interactions with host plants [
26]. The presence of these metabolites, synthesized via the STC pathways, highlights the intricate mechanisms through which B. cinerea exerts its pathogenicity and adapts to varying environmental conditions, making it a formidable adversary in agricultural settings [
18].
Table 6 delineates the domains associated with STCs in B. cinerea, emphasizing the diversity within this enzyme family. Notably, a singular domain, IPR008949, harbors previously characterized STCs alongside genes yet to be annotated. This domain's inclusion of 13 genes, with specific subsets sharing the IPR000092 and IPR024652 domains, underscores the complexity and potential expansiveness of the STC repertoire in B. cinerea. The detailed enumeration of these domains invites further investigation into their roles and contributions to the fungal secondary metabolism.
As detailed in
Table 7, a comprehensive domain-based analysis has led to the identification of three genes associated with STC domains. Specifically, three genes have been identified within the Isoprenoid synthase domain superfamily (IPR008949), one gene within the Polyprenyl synthetase domain (IPR000092), and one gene within the Trichodiene synthase domain (IPR024652). Notably, the latter two genes are also classified under the domain IPR008949, bringing the total to three new genes identified as part of this family. This expansion of the potential gene pool represents a significant extension beyond the currently characterized STCs in
B. cinerea, paving the way for further exploration into previously unexplored facets of its secondary metabolism.
Table 7.
Genes located in the domains that code for possible STCs in B. cinerea.
Table 7.
Genes located in the domains that code for possible STCs in B. cinerea.
Isoprenoid synthase domain superfamily. Domain: IPR008949 (Gene 3D) |
Name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
Bcstc5 |
Bcin01g03520 |
|
|
|
|
NA |
NA |
Bcphs1 |
Bcin01g04560 |
|
|
|
|
Bccoq1 |
Bcin02g05540 |
|
♦ |
|
|
Bcin14g01170 |
NA |
Bcstc4 |
Bcin04g03550 |
|
|
|
|
NA |
Bcstc3 |
Bcpax1 |
Bcin05g05670 |
|
♦ |
|
|
NA |
Bcerg9 |
Bcin06g02400 |
|
|
|
|
Bcstc2 |
Bcin08g02350 |
|
|
|
|
- |
Bcin08g03510 |
|
|
|
|
- |
Bcin11g06510 |
|
|
|
|
Bcbot2 /stc1 |
Bcin12g06390 |
|
|
|
|
Bcstc3 |
Bcin13g05830 |
|
|
|
|
Bcstc4 |
- |
Bcin14g01170 |
|
♦ |
|
|
Bccoq1 |
Bcerg20 |
Bcin15g03120 |
|
♦ |
|
|
NA |
|
|
|
|
|
|
|
|
Polyprenyl synthetase. Domain IPR000092 (Pfam) |
There are the genes Bccoq1, Bcpax1, Bcerg20 and Bcin14g01170 |
|
Trichodiene synthase. Domain IPR024652 (Pfam) |
There are the genes Bcstc2 and Bcin11g06510 |
1 |
|
EnsemblFungi. Biological process: GO:1901362 organic cyclic compound biosynthetic process. IEA. |
2 |
|
EnsemblFungi. Biological process. GO:0009058 biosynthetic process. IEA. |
♦ |
EnsemblFungi. Biological process. GO:0008299 isoprenoid biosynthetic process |
3 |
|
NCBI: cl00210 Isoprenoid Biosynthesis enzymes, Class 1. |
4 |
|
Fungi DB. Uniprot. SSF48576. Terpenoid synthases superfamily (SUPFAM) |
2.4. Genes Located in Domains That Code for Possible DTCs in B. cinerea
In
Section 2.4, attention is turned towards the characterization of genes associated with Diterpene Cyclases (DTCs), a class of enzymes integral to the biosynthesis of diterpenes. Diterpenes are a diverse group of secondary metabolites known for their role in plant-microbe interactions, including defence mechanisms against phytopathogens. In
B. cinerea, the exploration of DTCs illuminates new aspects of its secondary metabolism, potentially revealing pathways involved in the synthesis of diterpenoid compounds [
27]. The intricate nature of these pathways underscores the fungus's sophisticated adaptability and pathogenic arsenal.
In the comprehensive analysis of
B. cinerea's diterpene cyclases (DTCs) within the IPR008930 domain, a detailed examination has unveiled five genes, with
Bcdtc1 being particularly notable for its well-established diterpene cyclase activity. This discovery, as presented in
Table 8, emphasizes
Bcdtc1's distinct role within the domain. It's important to note, however, that while
Bcdtc2 and
Bcdtc3 have traditionally been recognized as part of the secondary metabolism gene set in
B. cinerea, current investigations reveal that Bcdtc2 no longer has available information, and Bcdtc3 does not align with any domain typically associated with this family [
18]. Despite this, the domain IPR008930 encompasses five genes, inclusive of Bcdtc1, underscoring a specialized contribution towards diterpene synthesis in
B. cinerea. Furthermore, this analysis has led to the discovery of an additional, yet unannotated, gene (Bcin02g00670), emerging as a new candidate within the scope of the fungus's secondary metabolism.
Table 8.
Genes located in the domains that code for possible DTCs in B. cinerea.
Table 8.
Genes located in the domains that code for possible DTCs in B. cinerea.
Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid. Domain: IPR008930 (Superfamily) |
name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
4 |
Undescribed |
Known |
Bccdc43 |
Bcin01g04020 |
|
|
|
|
NA |
Bcram1 and Bcbet2 |
Bcdtc1 |
Bcin01g04920 |
|
|
|
|
Bcdtc3 |
- |
Bcin02g00670 |
Ξ |
# |
|
|
NA |
Bcram1 |
Bcin03g06350 |
|
|
|
|
Bccdc43 and Bcbet2 |
Bcbet2 |
Bcin06g05320 |
|
|
♦ |
|
NA |
1 |
Ξ |
EnsemblFungi. Biological process: GO:0006694 steroid biosynthetic process. IEA. |
2 |
# |
EnsemblFungi. Biological process. GO:0016104 triterpenoid biosynthetic process. IEA. |
3 |
|
NCBI: cd02895: Geranylgeranyltransferase types I |
♦ |
NCBI: cd02894: Geranylgeranyltransferase type II |
|
NCBI: cl27572: Terpene synthase, N-terminal domain |
|
NCBI: cd02892: Squalene cyclase (SQCY) domain subgroup 1 |
|
NCBI: cd02893: Protein farnesyltransferase (FTase) |
4 |
|
Fungi DB. Uniprot. SSF48239 Terpenoid cyclases/Protein prenyltransferases (SUPFAM) |
2.5. Genes Located in Domains That Code for Possible DMATSs in B. cinerea
In our pursuit of genes coding for the two known DiMethylAllylTryptophan Synthases in
B. cinerea, we have discerned that these genes coalesce within two distinct domains, IPR017795 and IPR033964. Notably, within the latter, a hitherto unidentified gene emerges, augmenting our insights into the genetic landscape of this phytopathogen. The encapsulation of this discovery is delineated in
Table 9, signifying a pivotal expansion of our knowledge concerning the enzymatic repertoire of this fungus.
Table 9 showcases the DMATS domains identified in
B. cinerea, highlighting two main domains: IPR017795 (Aromatic prenyltransferase DMATS-type) and IPR033964 (Aromatic prenyltransferase). It lists known genes,
Bcdmats2 and
Bcdmats1, alongside a new, unannotated gene found within the IPR033964 domain. This table serves as a critical update to the DMATS gene inventory for the B05.10 strain of this fungus.
Table 9.
Genes located in the domains that code for possible DMATS in B. cinerea.
Table 9.
Genes located in the domains that code for possible DMATS in B. cinerea.
Aromatic prenyltransferase, DMATS-type. Domain: IPR017795 (Pfam) |
Name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
Undescribed |
Known |
Bcdmats2 |
Bcin14g04900 |
|
|
|
NA |
NA |
Bcdmats1 |
Bcin16g01940 |
|
|
|
|
|
|
|
|
|
|
Aromatic prenyltransferase. Domain: IPR033964 (SFLD) |
There are the genes Bcdmats2 and Bcdmats1
|
Name |
ID |
Relationship with secondary metabolism |
paralogues genes |
1 |
2 |
3 |
Undescribed |
Known |
- |
Bcin06g02600 |
♦ |
♦ |
|
NA |
NA |
1 |
|
EnsemblFungi. Biological process: GO:0009820 alkaloid metabolic process. IEA. |
♦ |
EnsemblFungi. Molecular function. GO:0004659 prenyltransferase activity. IEA. |
2 |
|
NCBI: cd13929: aromatic prenyltransferases (PTases) of the DMATS/CymD familiy |
♦ |
NCBI: pfam11468: Aromatic prenyltransferase Orf2 |
3 |
|
Fungi DB. Uniprot. PTHR40627. Indole prenyltransferase tdib-related (PANTHER) |
The scrutiny of DMATS domains as articulated in
Table 9 has unveiled the presence of an additional, previously unannotated gene within the IPR033964 domain. This discovery not only enriches our list of DMATS genes in
B. cinerea but also alludes to the potential existence of untapped metabolic pathways that could play a pivotal role in the organism's adaptability and pathogenic capabilities [
18].
2.6. New Candidate Genes Possibly Related to the Secondary Metabolism of B. cinerea
In consolidating our findings from the comprehensive bioinformatics analyses of B. cinerea's genome, we have unveiled an expanded repertoire of genes implicated in the synthesis of secondary metabolites. Through this study's journey across the diverse enzymatic landscapes of PKS, NRPS, STC, DTC, and DMATS, we have illuminated the genetic underpinnings contributing to the pathogen's complexity and virulence. The compilation of newly identified genes in
Table 10 represents a pivotal enhancement of the known gene pool associated with these critical families. Moreover, the classification into groups such as NRPS, PKS-NRPS hybrids, and potentially other hybrid forms, as informed by the current databases, introduces a layer of complexity in precisely defining these genes' roles. This nuance highlights the evolving nature of our understanding, acknowledging that some genes might exhibit functionalities of one or more enzyme types related to secondary metabolism (SM). The elucidation of these genes not only broadens our understanding of B. cinerea's metabolic capacities but also underscores the dynamic evolution of its genome in adapting to various ecological niches and host interactions.
In this updated examination of B. cinerea's secondary metabolism genes, critical adjustments and noteworthy additions have been made to the gene catalog. Particularly, the Bcdtc2 gene has been excluded from our considerations due to its absence in recent database records. Additionally, the Bcbik genes, once presumed relevant to secondary metabolism, are identified as non-functional for the B05.10 strain, thereby not contributing to bikaverin production [
28]. Furthermore, the Bcphs1 gene designation revealed two genes, Bcin08g03790 and Bcin01g04560, with the former being a novel discovery warranting further investigation due to its potential involvement in retinal production, unlike the previously studied Bcin01g04560 [
29].
Most notably, the gene Bcin11g06510, now classified as Bcstc7, represents a significant addition to the B. cinerea gene repertoire. Initial transcriptomic, metabolomic, and phenotypic characterizations suggest Bcstc7 as a key enzyme in the biosynthesis of eremophilenol, marking the first documentation of this biosynthetic pathway in the fungus [
26]. The comprehensive list in
Table 10, marking the culmination of our search, not only enhances the catalog of known secondary metabolism genes but also sets the stage for future research endeavors aimed at unraveling the metabolic complexity and ecological strategies of this phytopathogen.
3. Discussion
In the comprehensive investigation presented within this study, we embarked on a detailed exploration of the secondary metabolism of B. cinerea, focusing specifically on the genetic underpinnings of its biosynthetic capabilities. Through the meticulous bioinformatic analysis of known and novel gene families—namely Polyketide Synthases (PKS), Non-Ribosomal Peptide Synthetases (NRPS), Sesquiterpene Cyclases (STC), Diterpene Cyclases (DTC), and DiMethylAllylTryptophan Synthases (DMATS)—this research has significantly advanced our understanding of the molecular basis for the diverse array of secondary metabolites produced by this phytopathogenic fungus. The localization of these genes provides not only a deeper insight into the metabolic complexity of B. cinerea but also illuminates the evolutionary strategies it employs to thrive within its ecological niche and against its plant hosts.
The findings reported herein contribute to a growing body of evidence that underscores the dynamic nature of fungal secondary metabolism, revealing an intricate network of genetic elements that drive the synthesis of compounds essential for pathogenicity, survival, and competition. The identification of a multitude of previously unannotated genes across these key enzymatic families opens new avenues for research into the specific roles these genes play in the life cycle of B. cinerea, their potential impact on host-pathogen interactions, and their implications for agricultural management practices.
The elucidation of new Polyketide Synthase (PKS) genes within the genome of
B. cinerea marks a significant advancement in our understanding of the fungal arsenal against plant hosts. The identification of these genes not only enriches the catalog of known PKS in this phytopathogen but also provides insights into the potential for an expanded repertoire of polyketides, compounds known for their critical roles in fungal virulence and adaptability. The presence of these newly discovered PKS genes suggests an evolutionary advantage for
B. cinerea, enabling the fungus to synthesize a broader array of polyketides that may contribute to its pathogenicity and survival in diverse environmental conditions [
17].
Comparatively, this expansion mirrors findings in other phytopathogenic fungi, where the diversity of PKS genes correlates with the organism's ability to infect its host and evade plant defenses. For instance, studies in fungi such as
Fusarium graminearum and
Aspergillus nidulans have demonstrated the pivotal role of PKS-derived metabolites in host-pathogen interactions, underscoring the evolutionary pressure on these organisms to diversify their metabolic capabilities. Our findings in
B. cinerea add to this narrative, suggesting that the expansion of the PKS gene family is a conserved strategy among fungi to enhance their pathogenic toolkit [
30]. Moreover, the discovery of these PKS genes in
B. cinerea not only has implications for our understanding of fungal pathogenesis but also highlights potential targets for the development of novel antifungal strategies. By elucidating the functions and products of these newly identified genes, future research may pave the way for innovative approaches to control
B. cinerea infections, potentially reducing the agricultural and economic impact of this pathogen [
19].
The advancement in genomic exploration has led to the significant identification of an expanded repertoire of Non-Ribosomal Peptide Synthetase (NRPS) genes in
B. cinerea. This expansion not only augments our comprehension of the NRPS gene family within this formidable phytopathogen but also sets the stage for a deeper investigation into the myriad of secondary metabolites these genes are poised to produce. The NRPS enzymes are quintessential for the synthesis of a wide range of non-ribosomal peptides, many of which play pivotal roles in the pathogenicity and environmental adaptability of fungi. The diversity of NRPS genes uncovered in
B. cinerea hints at a sophisticated arsenal capable of synthesizing diverse bioactive compounds, potentially contributing to the fungus's success as a pathogen across a broad spectrum of host plants [
23]. The functional diversity suggested by the newly identified NRPS domains in
B. cinerea speaks to the evolutionary pressure on this pathogen to innovate its metabolic pathways. These peptides, often characterized by their complex structures and specific biological activities, can include toxins, siderophores, and immunosuppressants, among others, each contributing uniquely to the pathogen's interaction with its host and survival within competitive microbial ecologies. For example, the production of siderophores, which sequester iron from the host or environment, showcases a direct link between NRPS activity and fungal virulence, underscoring the critical role these enzymes play in pathogen survival and proliferation [
31].
The identification of novel NRPS genes aligns with findings in other pathogenic fungi, where the variability and abundance of these genes have been correlated with a heightened capacity for host invasion and colonization. This suggests that the NRPS gene family's expansion within B. cinerea may be reflective of similar evolutionary adaptations, enabling a more versatile and robust engagement with host defenses. Such an adaptive mechanism is indicative of the pathogen's evolved strategies to ensure survival and pathogenic success, hinting at a complex interplay between fungal metabolism and host defense mechanisms. Additionally, the discovery of these genes opens new avenues for antifungal drug discovery. By targeting the unique enzymatic mechanisms of NRPSs, novel therapeutic strategies can be developed to mitigate the impact of B. cinerea on agriculture without relying on traditional fungicides that pose risks of resistance development and environmental harm. This strategic approach towards antifungal intervention underscores the critical importance of understanding the functional diversity and biological roles of NRPSs in B. cinerea's lifecycle and pathogenicity.
The integration of Sesquiterpene Cyclases (STC) in our study provides critical insights into the biosynthesis of sesquiterpenes in
B. cinerea and their integral role in the interaction between pathogen and host. Sesquiterpenes, known for their diverse and complex structures, play significant roles in fungal defense mechanisms and in mediating interactions with plant hosts. The identification of new STC genes in
B. cinerea not only enhances our understanding of the sesquiterpene biosynthetic pathways but also offers clues to the chemical diversity employed by this fungus to adapt and thrive in various ecological niches. This expanded genetic repertoire suggests a sophisticated mechanism by which
B. cinerea can produce sesquiterpenes that contribute to its virulence and ability to overcome plant defense systems, indicating a critical area for future research on pathogen-host dynamics [
26,
27]. Similarly, the exploration of Diterpene Cyclases (DTC) genes within
B. cinerea uncovers new dimensions of the fungus's ability to synthesize diterpenes, compounds less characterized in fungal secondary metabolism yet known for their potential roles in fungal development and host interactions. The discovery of DTC genes paves the way for understanding the biosynthesis of diterpenes in
B. cinerea, shedding light on their functions and implications in fungal physiology and pathogenicity. Intriguingly, the diterpenes' scarce representation in the known metabolome of
B. cinerea raises questions about their roles and prevalence within this fungal species. This gap in knowledge opens up avenues for intensive research, suggesting that a deeper investigation into the DTC-mediated diterpene biosynthesis could reveal novel metabolites with significant ecological and pathogenic relevance. The potential of these diterpenes to act as virulence factors or modulators of plant immune responses makes them compelling subjects for future studies, aiming to elucidate their contributions to the sophisticated interplay between
B. cinerea and its host plants [
25].
The recent discovery of a new DiMethylAllylTryptophan Synthase (DMATS) gene within the
B. cinerea genome represents a significant milestone in fungal secondary metabolism research. DMATS enzymes are key players in the biosynthesis of indole-derived secondary metabolites, which are pivotal for various biological processes including microbial competition, plant-microbe interactions, and pathogenesis. The identification of this gene provides new outlooks for understanding the biosynthetic capabilities of
B. cinerea, offering insights into previously unexplored routes leading to the production of novel indole derivatives. These compounds could have profound implications for the pathogen's adaptability, virulence, and resistance mechanisms against plant defense compounds [
13].
The potential biosynthetic pathways and products mediated by this newly identified DMATS gene could significantly enhance our comprehension of the chemical ecology of
B. cinerea. Given the crucial roles that indole-derived metabolites play in fungal pathogenicity and host interaction, elucidating these pathways may reveal novel targets for antifungal intervention. Indeed, the modulation of such pathways offers a promising avenue for the development of innovative crop protection strategies. By targeting specific enzymes or steps within these pathways, it might be possible to mitigate the virulence of
B. cinerea without affecting beneficial microbes, thereby reducing the reliance on broad-spectrum fungicides that pose risks of resistance development and environmental damage [
32].
Furthermore, the exploration of DMATS-mediated biosynthetic routes underscores the potential for discovering new natural products with applications beyond agriculture, including pharmaceuticals and industrial biotechnology. The versatility of indole derivatives as bioactive compounds highlights the importance of this gene discovery not only for plant pathology and crop protection but also for harnessing the synthetic potential of fungal secondary metabolites [
33].
Throughout this comprehensive study, we have significantly expanded our understanding of the secondary metabolism of
B. cinerea by identifying and characterizing key genes within the PKS, NRPS, STC, DTC, and DMATS gene families. These findings not only broaden the genetic repertoire associated with the production of secondary metabolites in this fungal pathogen but also underscore the complexity and diversity of mechanisms
B. cinerea utilizes to interact with its hosts and adapt to varying environments. The elucidation of these genes lays a solid foundation for future research aimed at understanding the specific biosynthetic pathways and metabolic products involved in fungal pathogenicity and resistance to plant defenses [
13,
19] .
From a biotechnological and crop disease management perspective, these discoveries hold vast potential for the development of novel and more effective disease control strategies. Manipulating these metabolic pathways through advanced genetic tools could allow to produce specific bioactive compounds with applications in agriculture, as well as in the pharmaceutical and chemical industries. Moreover, detailed knowledge of
B. cinerea's virulence mechanisms pave the way for the creation of plant cultivars with enhanced resistance, thus reducing dependency on chemical fungicides and contributing to more sustainable and environmentally friendly agricultural systems [
34]. Looking forward, it is evident that there is still much to uncover about the complex secondary metabolism of
B. cinerea. Future research prospects in this field include detailed exploration of the newly identified biosynthetic pathways, functional characterization of unknown metabolic products, and investigation of the specific molecular interactions between the pathogen and its hosts. Additionally, advancing our understanding of the genetic and epigenetic regulation of these biosynthetic systems to develop targeted and tailored interventions is essential. Continuing to expand our knowledge in these areas will not only enrich fundamental science in mycology and plant pathology but also have significant practical applications in crop protection and biotechnology.
5. Conclusions
This study represents a significant advancement in our understanding of the secondary metabolism of B. cinerea, uncovering an expanded spectrum of candidate genes implicated in the synthesis of secondary metabolites. The thorough integration of bioinformatics analyses with available genomic information has shed light on the genetic complexity underlying the pathogenicity and adaptability of this fungus. By exploring the enzymatic families of PKS, NRPS, STC, DTC, and DMATS, we have identified previously unannotated genes, offering new insights into the diversity and evolution of B. cinerea's genome.
The identification of these genes not only enriches our knowledge of B. cinerea's metabolic capabilities but also highlights the dynamic evolution of its genome, facilitating adaptations to diverse ecological niches and host interactions. The discovery of PKS-NRPS hybrid genes further underscores the complexity of this fungus's secondary metabolism, paving the way for the exploration of yet-unknown metabolic pathways. These findings are pivotal for advancing our understanding of the mechanisms through which B. cinerea interacts with its hosts and survives in varied environments.
The expansion of the genetic repertoire associated with the synthesis of secondary metabolites in B. cinerea carries significant implications for agricultural management and biotechnology. Manipulating these metabolic pathways, using advanced genetic tools, could lead to the production of specific bioactive compounds with applications in agriculture, as well as in the pharmaceutical and chemical industries. Moreover, a detailed understanding of B. cinerea's virulence mechanisms will facilitate the creation of crops with enhanced resistance, reducing dependency on chemical fungicides and contributing to more sustainable and environmentally friendly agricultural systems.
Looking forward, much remains to be discovered about the complex secondary metabolism of B. cinerea. Future research prospects include the detailed exploration of newly identified biosynthetic pathways, functional characterization of unknown metabolic products, and investigation of specific molecular interactions between the pathogen and its hosts. Furthermore, advancing our understanding of the genetic and epigenetic regulation of these biosynthetic systems to develop targeted and tailored interventions is essential. Continuing to expand our knowledge in these areas will not only enrich fundamental science in mycology and plant pathology but also have significant practical applications in crop protection and biotechnology.